Stem Cell-Based Immunotherapies

Stem cell-based immunotherapies leverage the regenerative potential of stem cells to enhance the body's immune response against diseases, particularly cancer. By utilizing immune cells derived from stem cells, such as T-cells and natural killer (NK) cells, these therapies aim to target and eliminate tumor cells more effectively. Additionally, stem cells can be used to modulate the immune system, making them valuable in treating autoimmune disorders and enhancing tissue repair. This cutting-edge approach offers new hope for patients with cancers, chronic infections, and other immune-related conditions.

    Related Conference of Stem Cell-Based Immunotherapies

    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    August 28-29, 2025

    12th World Congress on Epigenetics and Chromosome

    London, UK
    September 16-17, 2025

    5th Experts Meeting on Plant, Cellular and Molecular Biology

    Madrid, Spain
    September 25-26, 2025

    18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

    Montreal, Canada
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain
    October 30-31, 2025

    Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

    Rome, Italy
    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Stem Cell-Based Immunotherapies Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in